These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 22832417)

  • 1. The effects of age and estrogen on stress responsivity in older women.
    Dumas JA; Albert KM; Naylor MR; Sites CK; Benkelfat C; Newhouse PA
    Am J Geriatr Psychiatry; 2012 Sep; 20(9):734-43. PubMed ID: 22832417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen administration negatively alters mood following monoaminergic depletion and psychosocial stress in postmenopausal women.
    Newhouse PA; Dumas J; Hancur-Bucci C; Naylor M; Sites CK; Benkelfat C; Young SN
    Neuropsychopharmacology; 2008 Jun; 33(7):1514-27. PubMed ID: 17700646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogen treatment impairs cognitive performance after psychosocial stress and monoamine depletion in postmenopausal women.
    Newhouse PA; Dumas J; Wilkins H; Coderre E; Sites CK; Naylor M; Benkelfat C; Young SN
    Menopause; 2010 Jul; 17(4):860-73. PubMed ID: 20616673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychological and endocrine responses to psychosocial stress and dexamethasone/corticotropin-releasing hormone in healthy postmenopausal women and young controls: the impact of age and a two-week estradiol treatment.
    Kudielka BM; Schmidt-Reinwald AK; Hellhammer DH; Kirschbaum C
    Neuroendocrinology; 1999 Dec; 70(6):422-30. PubMed ID: 10657735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Hormone Therapy on Cognition and Mood in Recently Postmenopausal Women: Findings from the Randomized, Controlled KEEPS-Cognitive and Affective Study.
    Gleason CE; Dowling NM; Wharton W; Manson JE; Miller VM; Atwood CS; Brinton EA; Cedars MI; Lobo RA; Merriam GR; Neal-Perry G; Santoro NF; Taylor HS; Black DM; Budoff MJ; Hodis HN; Naftolin F; Harman SM; Asthana S
    PLoS Med; 2015 Jun; 12(6):e1001833; discussion e1001833. PubMed ID: 26035291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Oral vs Transdermal Estrogen Therapy on Sexual Function in Early Postmenopause: Ancillary Study of the Kronos Early Estrogen Prevention Study (KEEPS).
    Taylor HS; Tal A; Pal L; Li F; Black DM; Brinton EA; Budoff MJ; Cedars MI; Du W; Hodis HN; Lobo RA; Manson JE; Merriam GR; Miller VM; Naftolin F; Neal-Perry G; Santoro NF; Harman SM
    JAMA Intern Med; 2017 Oct; 177(10):1471-1479. PubMed ID: 28846767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of estradiol on neural and emotional stress response in postmenopausal women with remitted Major Depressive Disorder.
    Albert KM; Boyd BD; Taylor WD; Newhouse PA
    J Affect Disord; 2021 Oct; 293():355-362. PubMed ID: 34233228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive response to estradiol in postmenopausal women is modified by high cortisol.
    Baker LD; Asthana S; Cholerton BA; Wilkinson CW; Plymate SR; Green PS; Merriam GR; Fishel MA; Watson GS; Cherrier MM; Kletke ML; Mehta PD; Craft S
    Neurobiol Aging; 2012 Apr; 33(4):829.e9-20. PubMed ID: 21855173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of intranasal 17beta-estradiol on bone turnover and serum insulin-like growth factor I in postmenopausal women.
    Garnero P; Tsouderos Y; Marton I; Pelissier C; Varin C; Delmas PD
    J Clin Endocrinol Metab; 1999 Jul; 84(7):2390-7. PubMed ID: 10404809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early Postmenopausal Transdermal 17β-Estradiol Therapy and Amyloid-β Deposition.
    Kantarci K; Lowe VJ; Lesnick TG; Tosakulwong N; Bailey KR; Fields JA; Shuster LT; Zuk SM; Senjem ML; Mielke MM; Gleason C; Jack CR; Rocca WA; Miller VM
    J Alzheimers Dis; 2016 May; 53(2):547-56. PubMed ID: 27163830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy on climacteric symptoms of a continuous combined regimen of 1 mg 17beta-estradiol and trimegestone versus two regimens combining 1 or 2 mg 17beta-estradiol and norethisterone acetate.
    Gambacciani M; Spielmann D; Genazzani AR
    Gynecol Endocrinol; 2005 Aug; 21(2):65-73. PubMed ID: 16294457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular Effects of Early versus Late Postmenopausal Treatment with Estradiol.
    Hodis HN; Mack WJ; Henderson VW; Shoupe D; Budoff MJ; Hwang-Levine J; Li Y; Feng M; Dustin L; Kono N; Stanczyk FZ; Selzer RH; Azen SP;
    N Engl J Med; 2016 Mar; 374(13):1221-31. PubMed ID: 27028912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Timing of Estradiol Treatment After Menopause May Determine Benefit or Harm to Insulin Action.
    Pereira RI; Casey BA; Swibas TA; Erickson CB; Wolfe P; Van Pelt RE
    J Clin Endocrinol Metab; 2015 Dec; 100(12):4456-62. PubMed ID: 26425886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of micronized progesterone added to non-oral estradiol on lipids and cardiovascular risk factors in early postmenopause: a clinical trial.
    Casanova G; Spritzer PM
    Lipids Health Dis; 2012 Oct; 11():133. PubMed ID: 23046709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute estradiol treatment reduces skeletal muscle protein breakdown markers in early- but not late-postmenopausal women.
    Park YM; Keller AC; Runchey SS; Miller BF; Kohrt WM; Van Pelt RE; Kang C; Jankowski CM; Moreau KL
    Steroids; 2019 Jun; 146():43-49. PubMed ID: 30928279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of continuous combined estradiol-norethisterone acetate preparations on insulin sensitivity in postmenopausal nondiabetic women.
    Kimmerle R; Heinemann L; Heise T; Bender R; Weyer C; Hirschberger S; Berger M
    Menopause; 1999; 6(1):36-42. PubMed ID: 10100178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of a continuous once-a-week 17beta-estradiol/levonorgestrel transdermal system and its effects on vasomotor symptoms and endometrial safety in postmenopausal women: the results of two multicenter, double-blind, randomized, controlled trials.
    Shulman LP; Yankov V; Uhl K
    Menopause; 2002; 9(3):195-207. PubMed ID: 11973443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral 17β-estradiol/progesterone (TX-001HR) and quality of life in postmenopausal women with vasomotor symptoms.
    Simon JA; Kaunitz AM; Kroll R; Graham S; Bernick B; Mirkin S
    Menopause; 2019 May; 26(5):506-512. PubMed ID: 30489424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postmenopausal oral estrogen therapy and blood pressure in normotensive and hypertensive subjects: the Estrogen in the Prevention of Atherosclerosis Trial.
    Steiner AZ; Hodis HN; Lobo RA; Shoupe D; Xiang M; Mack WJ
    Menopause; 2005; 12(6):728-33. PubMed ID: 16278616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of oral estradiol dose/levels with coagulation measures in early/late postmenopausal women.
    Sriprasert I; Hodis HN; Bernick B; Mirkin S; Mack WJ
    Climacteric; 2020 Jun; 23(3):273-278. PubMed ID: 31939316
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.